Badri N Dasu Acelrx Pharmaceuticals Inc (ACRX) insider trading activity

Badri N Dasu is Chief Engineering Officer of ACELRX PHARMACEUTICALS INC. Currently has a direct ownership of 31,414 shares of ACRX, which is worth approximately $35,497. The most recent transaction as insider was on Mar 03, 2024, when has been sold 406 shares (Common Stock) at a price of $1.3 per share, resulting in proceeds of $527. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.4K

0% 3M change

67.35% 12M change

Total Value Held $35,497

Badri N Dasu Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2024	SELL Payment of exercise price or tax liability	$527 $1.3 p/Share	406 Reduced 1.28%	31,414 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	14,667 Added 31.55%	31,820 Common Stock
Feb 11 2024	SELL Payment of exercise price or tax liability	$889 $1.1 p/Share	809 Reduced 4.5%	17,153 Common Stock
Feb 10 2024	SELL Payment of exercise price or tax liability	$889 $1.1 p/Share	809 Reduced 4.31%	17,962 Common Stock
Mar 03 2023	SELL Payment of exercise price or tax liability	$521 $1.31 p/Share	398 Reduced 2.08%	18,771 Common Stock
Feb 11 2023	SELL Payment of exercise price or tax liability	$1,303 $1.68 p/Share	776 Reduced 3.89%	19,169 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	4,875 Added 19.64%	19,945 Common Stock
Feb 06 2023	SELL Payment of exercise price or tax liability	$925 $2.02 p/Share	458 Reduced 2.95%	15,070 Common Stock
Mar 03 2022	SELL Payment of exercise price or tax liability	$2,301 $0.41 p/Share	5,612 Reduced 1.83%	300,595 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	$2,246 $0.4 p/Share	5,615 Reduced 1.86%	296,207 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	97,500 Added 24.42%	301,822 Common Stock
Feb 06 2022	SELL Payment of exercise price or tax liability	$2,937 $0.43 p/Share	6,830 Reduced 3.23%	204,322 Common Stock
Mar 03 2021	BUY Grant, award, or other acquisition	-	50,000 Added 19.63%	204,757 Common Stock
Feb 11 2021	SELL Payment of exercise price or tax liability	$17,818 $2.63 p/Share	6,775 Reduced 4.47%	144,757 Common Stock
Feb 06 2021	SELL Payment of exercise price or tax liability	$17,731 $2.59 p/Share	6,846 Reduced 4.32%	151,532 Common Stock

BND

Badri N Dasu

Chief Engineering Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRX shares.

Notify only if

Value

Insider Trading

Get notified when an Acelrx Pharmaceuticals Inc insider buys or sells ACRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACELRX PHARMACEUTICALS INC

Track Activities on ACRX

Account